COEBRA is an AI-native market access platform built for biopharma — unifying payer engagement intelligence, value-based contracting, and revenue management into one intelligent system. Fragmented data and legacy tools delay patient access and erode commercial value. COEBRA replaces the patchwork with a single, high-precision operating system that gives biopharma teams real-time visibility, automated workflows, and AI-driven insights across the entire market access lifecycle. Our platform brings together three integrated products: → AccessIQ — AI-powered payer engagement intelligence that surfaces evidence gaps, tracks policy alignment, and accelerates formulary access decisions. → ValueIQ — Value-based contract management that automates term extraction, adjudication rules, and payer compliance tracking in real time. → RevenueIQ — Rebate management, gross-to-net forecasting, and 340B duplicate discount monitoring that protects and recovers net revenue. COEBRA deploys in weeks — not months. Our AI handles the complexity so your team can focus on strategy, not data wrangling. Trusted by leading biopharma companies in the most complex access environments. Market Access Clarity. Revenue Confidence.
| Website | https://www.coebra.ai/ |
| Employees | 2 (1 on RocketReach) |
| Founded | 2020 |
| Address | 851 Duportail Rd Fl 2, Chesterbrook, Pennsylvania 19087, US |
| Industry | Health and Human Services |
Looking for a particular COEBRA.ai employee's phone or email?
Usama Malik is the President | GM | Product Founder COEUS Healthcare LLC. of COEBRA.ai.
1 people are employed at COEBRA.ai.
COEBRA.ai is based in Chesterbrook, Pennsylvania.